03/02/2021
6:15 PM | Halozyme Therapeutics (Issuer)
Sun Elaine D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2021
7:08 PM | Halozyme Therapeutics (Issuer)
Kelley Kenneth J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2021
7:06 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2021
7:03 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2021
5:06 AM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2021
3:16 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2021
3:12 PM | Halozyme Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/22/2021
5:28 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2021
5:27 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/17/2021
4:05 PM | Halozyme Therapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/17/2021
4:04 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/17/2021
4:03 PM | Halozyme Therapeutics (Issuer)
Sun Elaine D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/17/2021
4:02 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2021
6:10 PM | Halozyme Therapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2021
6:07 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2021
6:06 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2021
9:57 AM | Halozyme Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/10/2021
5:17 AM | Artisan Partners Limited Partnership (Filed by)
Halozyme Therapeutics (Subject)
| Form SC 13G/A
| |
02/01/2021
5:56 PM | Halozyme Therapeutics (Issuer)
Kelley Kenneth J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2021
5:55 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/26/2021
1:22 PM | BlackRock Inc. (Filed by)
Halozyme Therapeutics (Subject)
| Form SC 13G/A
| |
01/13/2021
4:11 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/11/2021
7:07 AM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2021
4:07 PM | Halozyme Therapeutics (Issuer)
Kelley Kenneth J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2020
5:01 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/08/2020
3:56 PM | BlackRock Inc. (Filed by)
Halozyme Therapeutics (Subject)
| Form SC 13G
| |
12/07/2020
5:05 PM | Halozyme Therapeutics (Issuer)
Kelley Kenneth J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2020
4:55 PM | Halozyme Therapeutics (Issuer)
Kelley Kenneth J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2020
6:57 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2020
4:43 PM | Halozyme Therapeutics (Issuer)
Kelley Kenneth J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2020
5:59 PM | Halozyme Therapeutics (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2020
5:57 PM | Daly James M (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2020
5:56 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2020
5:25 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2020
3:11 PM | Halozyme Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2020
3:04 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/20/2020
3:53 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/21/2020
6:30 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2020
4:33 PM | Halozyme Therapeutics (Issuer)
MATSUI CONNIE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2020
5:13 PM | Halozyme Therapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2020
3:21 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2020
5:43 PM | Daly James M (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2020
3:03 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/20/2020
5:33 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2020
5:39 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2020
3:11 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2020
3:09 PM | Halozyme Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2020
6:15 PM | Halozyme Therapeutics (Issuer)
Posard Matthew L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2020
6:14 PM | Halozyme Therapeutics (Issuer)
MATSUI CONNIE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2020
6:12 PM | Halozyme Therapeutics (Issuer)
Kelley Kenneth J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2020
6:12 PM | Halozyme Therapeutics (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2020
6:11 PM | Daly James M (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2020
6:10 PM | Connaughton Bernadette (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2020
6:09 PM | BIZZARI JEAN-PIERRE (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2020
8:42 AM | Artisan Partners Limited Partnership (Filed by)
Halozyme Therapeutics (Subject)
| Form SC 13G
| |
04/03/2020
7:03 AM | Halozyme Therapeutics (Filer)
| Form DEFA14A
| |
03/19/2020
6:28 PM | Halozyme Therapeutics (Issuer)
Kelley Kenneth J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2020
7:04 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2020
7:03 PM | Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2020
7:02 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
3:16 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
3:15 PM | Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2020
5:41 PM | Halozyme Therapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2020
5:39 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2020
5:38 PM | Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2020
5:24 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2020
5:05 PM | Halozyme Therapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2020
5:03 PM | Halozyme Therapeutics (Issuer)
LaBarre Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2020
4:59 PM | Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2020
4:56 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2020
1:24 PM | Halozyme Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/10/2020
12:41 PM | Halozyme Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/04/2020
3:11 PM | Halozyme Therapeutics (Issuer)
Torley Helen (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/28/2020
8:56 AM | Halozyme Therapeutics (Subject)
IRIDIAN ASSET MANAGEMENT LLC/CT (Filed by)
| Form SC 13G/A
| |
01/16/2020
3:25 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2020
3:23 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2019
4:02 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2019
5:06 AM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2019
3:15 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2019
3:53 PM | Halozyme Therapeutics (Subject)
KIRK RANDAL J (Filed by)
| Form SC 13D/A
| |
11/05/2019
3:36 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2019
6:10 PM | Halozyme Therapeutics (Issuer)
Hickey Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2019
10:20 AM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2019
3:18 PM | Halozyme Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2019
7:11 PM | Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
3:01 PM | Halozyme Therapeutics (Subject)
KIRK RANDAL J (Filed by)
| Form SC 13D/A
| |
06/17/2019
7:19 AM | Halozyme Therapeutics (Issuer)
Stelzer Laurie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
12:40 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2019
4:10 PM | Halozyme Therapeutics (Subject)
KIRK RANDAL J (Filed by)
| Form SC 13D/A
| |
06/03/2019
4:22 PM | Chondros Dimitrios (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2019
4:10 PM | Halozyme Therapeutics (Filer)
| Form S-8 POS
| |
05/07/2019
3:08 PM | Halozyme Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2019
3:01 PM | Armour Alison A. (Reporting)
Halozyme Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/03/2019
4:05 PM | Halozyme Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2019
3:23 PM | Halozyme Therapeutics (Issuer)
Posard Matthew L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2019
3:20 PM | Halozyme Therapeutics (Issuer)
MATSUI CONNIE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2019
3:12 PM | Daly James M (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2019
3:10 PM | Connaughton Bernadette (Reporting)
Halozyme Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2019
3:08 PM | Halozyme Therapeutics (Issuer)
LEONHARDT HARRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2019
3:07 PM | Halozyme Therapeutics (Filer)
| Form DEF 14A
| |
